# Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis

> **NCT02602600** · PHASE4 · COMPLETED · sponsor: **Eva Prescott** · enrollment: 33 (actual)

## Conditions studied

- Microvascular Angina

## Interventions

- **DRUG:** Liraglutide

## Key facts

- **NCT ID:** NCT02602600
- **Lead sponsor:** Eva Prescott
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11-19
- **Primary completion:** 2017-04-18
- **Final completion:** 2017-04-18
- **Target enrollment:** 33 (ACTUAL)
- **Last updated:** 2018-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02602600

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02602600, "Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02602600. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*